← Open Payments lookup

MARK CABAHUG: Open Payments

NPI 1922455898 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$586 in 21 payments from 9 companies in 2025. Trend: 2023 $607 · 2024 $739 · 2025 $586

Food & beverage: $586
CompanyPaymentsAmount
Amgen Inc.6$133
AstraZeneca Pharmaceuticals LP4$119
ABIOMED1$104
Novartis Pharmaceuticals Corporation3$67
Actelion Pharmaceuticals US, Inc.2$61
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)2$33
Boehringer Ingelheim Pharmaceuticals, Inc.1$28
Novo Nordisk Inc1$25
PFIZER INC.1$15

Products named: LOKELMA, LEQVIO, Repatha, FARXIGA, OPSUMIT, LifeVest, JARDIANCE, OPSYNVI.

Industry payments across NJ — which companies pay providers there.